Making personalized medicine more affordable

Annals of the New York Academy of Sciences
Naomi Aronson

Abstract

Precision medicine holds promise to solve the conundrums of clinical care. Foremost is the well-known but vexing problem of heterogeneity and the tyranny of the mean. Who will respond to a treatment? How can patients avoid the harms of treatments that will not work for them? And if we know who to treat, will that make care more efficient and less costly? But the converse can also be true: treatments become more expensive as the costs of development must be distributed across smaller populations. Next-generation sequencing is making genetic testing radically cheaper. But the costs of medical tests also include false-positive results, incidental findings, and the cascade of follow-up. The affordability of precision medicine is intertwined with the broader issue of affordability of our healthcare system, and will require all stakeholders to assume stewardship for access and sustainability.

References

Apr 1, 1991·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D G Fryback, J R Thornbury
Dec 7, 2000·Journal of the National Cancer Institute·H I Scher
Sep 18, 2001·Health Affairs·A M Garber
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Jan 14, 2005·Health Affairs·Stefan Timmermans, Aaron Mauck
Jan 30, 2009·The New England Journal of Medicine·Peter B Bach
Jun 19, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·John C O'DonnellMarilyn Dix Smith
Jul 2, 2009·The New England Journal of Medicine·John K Iglehart
Oct 10, 2009·Journal of the National Cancer Institute·Richard M SimonDaniel F Hayes
Jul 6, 2011·Annals of Internal Medicine·Steven Goodman, Kay Dickersin
Dec 22, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Phillip G FebboMarian L Birkeland
Jan 26, 2012·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Laura S GoldSean D Sullivan
Feb 10, 2012·Clinical Pharmacology and Therapeutics·J M KramerR M Califf
Mar 30, 2013·Journal of the National Cancer Institute·Robert E BristowWilliam A Cliby
Jun 20, 2013·Annals of Internal Medicine·Harlan M KrumholzRichard Lehman
Jun 22, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Robert C GreenUNKNOWN American College of Medical Genetics and Genomics
May 13, 2014·Journal of the American College of Radiology : JACR·Michal HornýAlan B Cohen
Jul 10, 2014·Health Affairs·Kathryn A PhillipsChristine B Weldon
Jun 1, 2012·Personalized Medicine·Mark R Trusheim, Ernst R Berndt

❮ Previous
Next ❯

Citations

Nov 7, 2015·Drug Discovery Today·Mark R Trusheim, Ernst R Berndt
Mar 18, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Anna Maria RiccioGiorgio Walter Canonica
Apr 30, 2016·BioData Mining·Franco MilicchioMattia Prosperi
Jul 1, 2016·Nature Reviews. Cardiology·Elliott M Antman, Joseph Loscalzo
Jan 20, 2017·British Journal of Cancer·Seán O HynesManuel Salto-Tellez
Jun 6, 2017·Nature Biotechnology·Huub SchellekensEnrico Mastrobattista
Aug 28, 2021·Journal of Personalized Medicine·Katherine Hicks-CourantStacy W Gray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.